Corrie P, Marshall A, Lorigan P, et al. Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence: final results for the AVAST-M Trial. J Clin Oncol 35, 2017 (suppl; abstr 9501).
Trends in overleving bij uitgezaaid melanoom: analyse 2013-2021
apr 2024 | Dermato-oncologie